MEDICAL UPDATE: Disappointing News On Convergent Combination Therapy
Being Alive Newsletter; Beling Alive/Los Angeles - September 93 Mark Katz MD and reported by Jim Stoecker
Last year's front page news heralding the results of in vitro tests of combination AZT/ddI/Neviropine was premature and indicated the danger of publishing scientific results by press release. The resulting hoopla and demand for large scale trials obscured the facts that research was sloppily done and published without adequate verification of data, and that some laboratory data was misread and failed to detect significant viral mutation occurring in the test tube.
Although the news is disappointing, the trials of convergent combination therapy are going forward; certainly no one is being harmed by them. Perhaps we may yet find efficacy. Meanwhile, the emphasis may shift to divergent combination therapy approaches.
930900
BA930906
AEGiS is made possible through unrestricted grants from Roxane Laboratories, the National Library of Medicine, and donations from users like you. Always watch for outdated information. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.
This information is designed to support, not replace, the relationship that exists between you and your doctor.